Inactive Instrument
Isracann Biosciences Inc. Stock Canadian Securities Exchange
Stocks
IPOT
CA46501D1087
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.06M 5.24M 4.9M 4.49M 8.45M 577M 8.59M 57.46M 22.55M 289M 22.77M 22.27M 956M | P/E 2021 |
-1.24x | P/E 2022 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 5.85M 5.06M 4.73M 4.33M 8.15M 557M 8.28M 55.44M 21.76M 279M 21.97M 21.49M 922M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
99.83% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Ajay Kala
CEO | Chief Executive Officer | - | 20/01/2023 |
Yana Popova
DFI | Director of Finance/CFO | 44 | 15/11/2017 |
Bob Mehr
PRN | Corporate Officer/Principal | - | 15/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Bromley
BRD | Director/Board Member | 36 | 19/12/2019 |
Yana Popova
BRD | Director/Board Member | 44 | 15/11/2017 |
George Vrabec
BRD | Director/Board Member | - | 15/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 176 | |
| +0.14% | -3.97% | -9.18% | -6.40% | 13.42B | |
| +0.85% | -4.86% | -31.19% | -56.13% | 5.09B | |
| -0.84% | -2.23% | +4.50% | -1.89% | 5.05B | |
| +4.49% | +0.59% | +6.32% | -29.15% | 4.21B | |
| +0.84% | -2.90% | -6.91% | -8.87% | 3.69B | |
| -4.39% | -3.50% | -2.12% | +4.52% | 3.54B | |
| +1.48% | -2.48% | -2.48% | +17.75% | 3.48B | |
| +3.37% | +1.21% | -11.98% | -18.33% | 2.49B | |
| +0.23% | -3.30% | -3.72% | +46.80% | 1.86B | |
| Average | +0.62% | -2.13% | -6.31% | -5.74% | 4.76B | |
| Weighted average by Cap. | +0.52% | -2.37% | -7.26% | -9.75% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -25.16M -21.76M -20.32M -18.64M -35.06M -2.39B -35.62M -238M -93.57M -1.2B -94.46M -92.4M -3.97B | -4.69M -4.06M -3.79M -3.48M -6.54M -447M -6.64M -44.48M -17.46M -224M -17.62M -17.24M -740M |
| Net Debt | -1.96M -1.69M -1.58M -1.45M -2.73M -186M -2.77M -18.56M -7.28M -93.42M -7.35M -7.19M -309M | -214K -185K -173K -159K -298K -20.36M -303K -2.03M -796K -10.21M -803K -786K -33.74M |
Employees
-
Sector
Pharmaceuticals
